Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs

Advancements in the treatment of multiple myeloma (MM) have resulted in an improvement in the survival rate. However, there continues to be an urgent need for improved therapies. The protein arginine methyltransferase, CARM1 (coactivator associated arginine methyltransferase 1), is emerging as a pot...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Molecular Therapy: Oncology
المؤلفون الرئيسيون:	Wei Ni, Swati Garg, Basudev Chowdhury, Martin Sattler, Dana Sanchez, Chengcheng Meng, Taisei Akatsu, Katherine A. Donovan, Jun Qi, Michelle Y. Wang, Cara Ann Starnbach, Xiaoxi Liu, Maria Tarazona Guzman, Wei Pin Teh, Richard Stone, James D. Griffin, Sara Buhrlage, Ellen Weisberg
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2025-03-01
الموضوعات:	MT: Regular Issue multiple myeloma MM immunomodulatory drugs IMiDs CARM1
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2950329925000219